Abstract | BACKGROUND: OBJECTIVES: Reviewing the antiemetics used over the past 20 years for this indication and comparing their efficacy. SEARCH STRATEGY: SELECTION CRITERIA: DATA COLLECTION AND ANALYSIS: We reviewed the selected studies, presented the reported incidence rates of PONV for each drug, and presented and interpreted the P values reported for the different comparisons. MAIN RESULTS: CONCLUSIONS: All antiemetics used in the last 20 years to prevent PONV are effective (some more than others) in women undergoing dilatation and curettage for pregnancy termination. However, there is a need for benefit and risk analyses of the different treatments.
|
Authors | Yoshitaka Fujii |
Journal | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
(Int J Gynaecol Obstet)
Vol. 111
Issue 1
Pg. 3-7
(Oct 2010)
ISSN: 1879-3479 [Electronic] United States |
PMID | 20598689
(Publication Type: Journal Article, Retracted Publication, Review)
|
Copyright | Copyright © 2010 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Antiemetics
- Benzimidazoles
- Hydroxyzine
- Ondansetron
- Dexamethasone
- ramosetron
- Metoclopramide
- Droperidol
- Propofol
|
Topics |
- Abortion, Therapeutic
(adverse effects)
- Antiemetics
(therapeutic use)
- Benzimidazoles
(therapeutic use)
- Dexamethasone
(therapeutic use)
- Dilatation and Curettage
(adverse effects)
- Droperidol
(therapeutic use)
- Drug Therapy, Combination
- Female
- Humans
- Hydroxyzine
(therapeutic use)
- Metoclopramide
(therapeutic use)
- Ondansetron
(therapeutic use)
- Postoperative Nausea and Vomiting
(drug therapy, prevention & control)
- Pregnancy
- Propofol
(therapeutic use)
- Randomized Controlled Trials as Topic
|